Section Arrow
Quote
SNSE.NASDAQ
- Sensei Biotherapeutics Inc
Quotes are at least 15-min delayed:2026/02/23 15:33 EST
Regular Hours
Last
 34.85
+1.35 (+4.03%)
Day High 
34.99 
Prev. Close
33.5 
1-M High
34 
Volume 
203.35K 
Bid
34.45
Ask
34.85
Day Low
28.81 
Open
32.88 
1-M Low
8.37 
Market Cap 
42.25M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 14.96 
20-SMA 12.27 
50-SMA 10.78 
52-W High 34 
52-W Low 5 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-19.14/-12.43
Enterprise Value
43.78M
Balance Sheet
Book Value Per Share
18.24
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
GOSSGossamer Bio0.4173-1.7127-80.41%-- 
IBRXImmunityBio9.645+0.945+10.86%-- 
VNDAVanda Pharmaceuticals8.115+2.355+40.89%-- 
IKTInhibikase Therapeutics1.855+0.095+5.40%3.74PE
ACLXArcellx113.795+49.685+77.50%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.